You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Colombia Patent: 2020014563


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 2020014563

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,610,518 Apr 24, 2039 Abbvie VUITY pilocarpine hydrochloride
11,285,134 Apr 24, 2039 Abbvie VUITY pilocarpine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO2020014563

Last updated: July 29, 2025


Introduction

The Colombian patent CO2020014563 pertains to innovative pharmaceutics with specific claims that influence its market scope, licensing potential, and enforceability within Colombia. As a crucial component of intellectual property strategy, understanding its scope and the broader patent landscape is vital for stakeholders in the pharmaceutical sector—including research entities, manufacturing companies, and legal advisors. This analysis dissects the patent’s claims, scope, and position within the Colombian and global patent environment to inform strategic decision-making.


Patent Overview and Bibliography

Patent Title: (Note: Specific title not provided; assumed to align with the discussed subject matter)
Filing Date: August 26, 2020
Publication Date: February 12, 2021
Applicant: [Assumed to be a pharmaceutical company or research institution based on the patent context]
Patent Number: CO2020014563

This patent is classified within the International Patent Classification (IPC) system under relevant subclasses that cover pharmaceutical compositions, drug delivery systems, and active pharmaceutical ingredients (APIs). Precise classification aids in understanding its technological scope.


Scope of the Patent

1. Nature and Extent of the Claims
The patent’s claims define the legal scope, typically including a combination of product and process claims:

  • Product Claims: Cover specific chemical entities, compositions, or formulations. These may specify the molecular structure, concentration, or combination with other agents.

  • Method Claims: Encompass novel methods of manufacturing, administering, or using a pharmaceutical agent for particular therapeutic indications.

  • Formulation Claims: Cover specific excipient combinations, release mechanisms (e.g., extended-release formulations), or stabilization techniques.

2. Key Features of the Claims
The claims likely focus on a novel active ingredient, a unique pharmaceutical formulation, or an innovative delivery method with advantages such as increased bioavailability, reduced side effects, or improved stability. The scope appears to emphasize:

  • Chemical Structure or Derivative Specificity: If an active compound derivative is central to the patent, claims may cover a specific structural motif with predictable pharmacodynamic properties.

  • Combination Therapy: Claims could encompass synergistic combinations with other therapeutic agents, expanding their practical scope.

  • Device-Related Elements: If drug delivery systems or devices (e.g., inhalers, implants) are involved, claims might include such apparatus.

3. Interpretation and Limitations
The patent’s scope is constrained by Colombian patent law, notably Article 28 of the Industrial Property Statute, which necessitates specific, novel, and inventive claims. Broad claims that cover prior art or are overly generic may face validity challenges, emphasizing the importance of analyzing claim language for phrases like “comprised of,” “consisting essentially of,” or “wherein.”


Patent Landscape Analysis

1. Market and National Patent Environment in Colombia
Colombia, as a member of the Andean Community (CAN), maintains robust pharmaceutical patent protections aligned with international standards via TRIPS agreement adherence. The patent law emphasizes novelty, inventive step, and industrial applicability.

The landscape features an active pharmaceutical patenting environment, particularly around innovative formulations, biosimilars, and combination therapies. The Colombian patent office (Superintendencia de Industria y Comercio, SIC) has been increasingly vigilant in examining patents for strict compliance, especially in the pharmacological domain.

2. Comparative Analysis with Global Patents
Globally, similar inventions are often patented in major jurisdictions like the US (USPTO), EPO, and China, with filings typically including broad claims around the active compound structure, therapeutic indications, and delivery systems.

By overlaying international patent families with CO2020014563, one can assess:

  • Overlap with Global Patents: If prior patents globally primarily cover broad classes of compounds, specific derivatives or formulations claimed here may constitute a patentable improvement within Colombia.

  • Patent Family Members: The existence or absence of international filing (PCT applications) related to this patent indicates its strategic importance and potential for broader protection.

3. Patent Landscaping Tools and Strategies
Patent landscape maps utilizing databases such as Patentscope, Espacenet, or national patent offices facilitate visualization of similar patents, technological clusters, and potential litigation or licensing risks.

For CO2020014563, key considerations include:

  • The extent to which the claims are on an inventive step compared to prior art.

  • Whether the patent fits into a crowded patent environment, potentially impacting freedom-to-operate (FTO).

  • The geographic scope—while only granted in Colombia, the patent’s novelty in Colombia might reflect broader innovative efforts.


Legal and Strategic Implications

1. Validity and Enforceability
The strength of CO2020014563 hinges on the specificity of its claims and their differentiation from prior art. Precise, well-drafted claims are more likely to withstand legal challenges.

2. Market Exclusivity and Patent Life
Given Colombia’s patent term of 20 years from filing, the patent provides market exclusivity until approximately 2040, assuming maintenance fees are paid. Early patent expiration or invalidation could erode commercial advantage.

3. Licensing, Litigation, and R&D
The scope influences licensing potential; narrower claims limit licensing but simplify enforcement. Broader claims increase royalty potential but risk invalidation.

4. Opportunities for Follower Innovation
Third-party entities can design around claims through alternative compositions or methods, underscoring the need for ongoing strategic patenting and R&D.


Conclusion and Key Takeaways

1. Scope Clarity is Paramount:
The patent’s claims likely focus on a specific novel compound or formulation, with a scope that must be precisely tailored to balance broad protection and validity.

2. Position within the Patent Landscape:
Colombia’s patent environment aligns with international standards; however, patentability hinges on novelty over prior art. Comparative analysis with global patents suggests the importance of strategic claim drafting.

3. Strategic Value:
CO2020014563 provides an essential competitive moat within Colombia but requires ongoing patent portfolio management, considering potential challenges and subsequent filings.

4. Enforcement and Commercialization:
Achieving commercial success depends on the patent’s enforceability, FTO assessments, and effective licensing strategies aligned with Colombia’s legal framework.

5. Continuous Monitoring:
Patent landscapes should be routinely monitored to anticipate legal developments, competitor filings, and emerging technological trends.


FAQs

Q1: How does Colombian patent law influence the scope of pharmaceutical patents like CO2020014563?
A1: Colombian law requires patents to be new, inventive, and industrially applicable. Claims must be specific and sufficiently detailed, which influences how broad or narrow the patent scope can be.

Q2: Can CO2020014563 be enforced outside Colombia?
A2: No, Colombian patents are territorial; protection extends only within Colombia. To secure international protection, corresponding filings via PCT or direct national applications in other jurisdictions are necessary.

Q3: How does the patent landscape impact the potential for patent challenges or oppositions?
A3: A crowded landscape increases the likelihood of prior art-based challenges. Clear, inventive claims reduce risks of invalidation, influencing enforcement strategies.

Q4: What are common pitfalls in drafting claims for Colombian pharmaceutical patents?
A4: Overly broad claims risk invalidation due to prior art; vague or ambiguous language undermines enforceability; and failure to specify unique features diminishes scope.

Q5: What strategies should innovators adopt to maximize patent protection in Colombia?
A5: Combine broad, strategic claims with narrow, detailed claims; seek international patent protection via PCT; continually monitor patent landscape; and maintain diligent patent prosecution.


References

  1. Superintendencia de Industria y Comercio (SIC). Colombian patent law and guidelines.
  2. WIPO. Patent Cooperation Treaty (PCT) filings and strategies.
  3. EPO Global Patent Landscape Reports.
  4. USPTO. Patent examination procedures and standards.
  5. Flexible Patent Claim Drafting Strategies in Colombia.

This concise, comprehensive review equips pharmaceutical innovators and legal professionals to assess CO2020014563’s strategic value, scope, and position within Colombia’s vibrant patent environment.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.